People: Osiris Therapeutics Inc (OSIR.OQ)
10.28USD
17 Jun 2013
$0.12 (+1.18%)
$10.16
$10.24
$10.28
$10.11
8,700
37,046
$14.43
$6.55
Williams, Michelle
Brief Biography
Dr. Michelle LeRoux Williams, Ph.D., is Chief Scientific Officer of Osiris Therapeutics, Inc. Dr. Williams joined Osiris in October 2001. Dr. Williams previously served as the Director of Orthopedics and in that role was responsible for the development of Osteocel from initial concept through market launch. Prior to joining the Company, Dr. Williams completed an NIH postdoctoral fellowship in tissue engineering at Columbia University, evaluating cellular constructs for the repair and regeneration of cartilage in arthritis patients. Dr. Williams earned a bachelor's degree in mechanical engineering from Rice University and a Ph.D. in biomedical engineering from Duke University.
Basic Compensation
| Total Annual Compensation, USD | Long-Term Incentive Plans, USD | All Other, USD | Fiscal Year Total, USD |
|---|---|---|---|
| 301,000 | -- | 91,500 | 392,500 |
Options Compensation
| Quantity | Market Value | |
|---|---|---|
| Excercisable | -- | -- |
| Unexercisable | -- | -- |
| Excercised | 1,250 | 7,162.00 |
| Name | Fiscal Year Total |
|---|---|
Peter Friedli |
-- |
C. Randall Mills |
736,400 |
Philip Jacoby |
280,367 |
Lode Debrabandere |
412,500 |
Michelle Williams |
392,500 |
Felix Gutzwiller |
-- |
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
